iTonic Holdings Ltd ITOC
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus
Chart by TradingView
1/9
Piotroski F — financial health
5.57
Altman Z″ — distress risk · safe
-0.2%
Dividend payout · safe
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Revenue | $523,031 | $448,196 | $628,591 |
| Gross profit | $327,351 | $381,155 | $470,828 |
| Operating income | -$5.2M | -$770,266 | -$306,680 |
| Net income | -$5.1M | -$660,588 | -$241,217 |
| Operating cash flow | -$3.2M | -$775,000 | -$63,636 |
| Free cash flow | -$3.2M | -$775,861 | — |
| Total assets | $9.1M | $6.7M | $1.6M |
| Total liabilities | $969,832 | $538,551 | $1.3M |
| Shareholders' equity | $8.1M | $6.2M | $306,272 |
| Ratios | |||
| Gross margin | 62.6% | 85.0% | 74.9% |
| Operating margin | -991.7% | -171.9% | -48.8% |
| Net margin | -974.7% | -147.4% | -38.4% |
| FCF margin | -618.6% | -173.1% | — |
| Return on assets | -56.0% | -9.8% | -14.9% |
| Return on equity | -62.7% | -10.7% | -78.8% |
| Current ratio | 8.83 | 12.40 | 0.44 |
| Revenue growth | 16.7% | -28.7% | — |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 5.57 (safe)
- Working capital / assets 0.399
- Retained earnings / assets -0.618
- EBIT / assets -0.57
- Equity / liabilities 8.379
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001970544 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.